Gainers

  • Autonomix Medical AMIX stock rose 30.3% to $4.95 during Monday's pre-market session. The market value of their outstanding shares is at $93.0 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Sarepta Therapeutics SRPT stock increased by 12.64% to $140.68. The company's market cap stands at $13.1 billion.
  • China SXT Pharmaceuticals SXTC stock increased by 11.92% to $2.44. The company's market cap stands at $1.3 million.
  • Barinthus Biotherapeutics BRNS shares moved upwards by 11.63% to $2.77. The market value of their outstanding shares is at $106.9 million.
  • Artivion AORT shares increased by 10.86% to $20.0. The market value of their outstanding shares is at $820.9 million. As per the press release, Q4 earnings came out 2 days ago.
  • Calidi Biotherapeutics CLDI shares rose 10.02% to $0.55. The company's market cap stands at $19.5 million.

Losers

  • Inventiva IVA shares fell 15.2% to $3.34 during Monday's pre-market session. The company's market cap stands at $172.4 million.
  • Hepion Pharmaceuticals HEPA stock declined by 12.97% to $2.35. The company's market cap stands at $10.1 million.
  • AMN Healthcare Services AMN shares decreased by 12.35% to $68.05. The market value of their outstanding shares is at $2.5 billion. As per the news, the Q4 earnings report came out 2 days ago.
  • Brainstorm Cell BCLI shares declined by 12.3% to $0.34. The market value of their outstanding shares is at $16.6 million.
  • Biophytis BPTS shares decreased by 10.61% to $0.5. The company's market cap stands at $4.8 million.
  • Orgenesis ORGS shares decreased by 8.75% to $0.44. The market value of their outstanding shares is at $13.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!